Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Vesselar
- Development stage
- Unknown
- Lead developer
- Innovision
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Vesselar is an oral dietary supplement formulated as a vegetable capsule containing a combination of nutrients, including omega-3 fatty acids (EPA/DHA), alpha lipoic acid, lutein, zeaxanthin, vitamins C and E, and zinc. Developed by Innovision, it is designed to support eye health, defend against diabetic retinopathy, and improve vision in patients with diabetes. The supplement utilizes a vegetable capsule made from hypromellose (HPMC) to deliver its active ingredients.
- Brand names
- Vesselar
- Other names
- Vesselar Vegetable Capsule Food Supplement
Beyond the preview
Go deeper on Vesselar.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Vesselar.